청소년기의 다낭성 난소증후군
Polycystic Ovary Syndrome in Adolescence
3
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Polycystic ovary syndrome (PCOS) is a syndrome of variable combinations of menstrual irregularity, hirsutism, and obesity. It is frequently diagnosed during adolescence and may be increasing in prevalence secondary to obesity among teenagers. It is associated with ovulatory dysfunction, hyperandrogenism, hyperinsulinism, and insulin resistance, and a major risk factor for metabolic syndrome and type 2 DM later in life. The goals of therapy in treating teenagers with PCOS has focused on managing body weight, improving self esteem by lessening acne and hirsutism, and regulating menses. Identifying girls at risk for PCOS and implementing treatment early in the development of PCOS may be an effective means of preventing some of the long-term complications associated with this syndrome.
Abstract
Polycystic ovary syndrome (PCOS) is a syndrome of variable combinations of menstrual irregularity, hirsutism, and obesity. It is frequently diagnosed during adolescence and may be increasing in prevalence secondary to obesity among teenagers. It is associated with ovulatory dysfunction, hyperandrogenism, hyperinsulinism, and insulin resistance, and a major risk factor for metabolic syndrome and type 2 DM later in life. The goals of therapy in treating teenagers with PCOS has focused on managing body weight, improving self esteem by lessening acne and hirsutism, and regulating menses. Identifying girls at risk for PCOS and implementing treatment early in the development of PCOS may be an effective means of preventing some of the long-term complications associated with this syndrome.
참고문헌 (35)
- Knochenhauer E.S., "Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern States: a prospective study", J Clin Endocrinol Metab, 83, pp.3078~3082 (1998)
- Khan U., "Polycystic ovary syndrome in adolescents", J Pediatr Adolesc Gynecol, 20, pp.101~104 (2007)
- Ibanez L., "Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth", J Clin Endocrinol Metab, 83, pp.3558~3562 (1998)
- Meas T., "Endocrine consequences of premature pubarche in postpubertal Caucasian girls", Clin Endocrinol (Oxf), 57, pp.101~106 (2002)
- Rosenfeld R.L., "Are adrenal and ovarian function normal in true precocious puberty?", Eur J Endocrinol, 133, pp.399~400 (1995)
- Baumann E., "Pseudo-Cushing syndrome and pseudoacromegalic gigantism associated with insulin resistant hyperinsulinism as childhood precursors of polycystic ovary syndrome", Pediatr Res, 51, pp.117~200 (2002)
- Buggs C., "Polycystic ovary syndrome in adolescence", Endocrinol Metab Clin North Am, 34, pp.677~705 (2005)
- Zawadski J.K., "Diagnosis criteria for polycystic ovary syndrome: Towards a rational approach,Polycystic Ovary Syndrome", pp.377~384 (1992), Boston: Blackwell Scientific Publications
- The Rotterdam ESHRE, "ASRM-Sponsored PCOS Consensus Workshop Group", consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, 2004, pp.81, 19~25
- Azziz R., "Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline", J Clin Endocrinol Metab, 91, pp.4237~4245 (2006)
- Legro R.S., "Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome", Proc Natl Acad Sci USA, 통권 : 95, pp.14956~14960 (1998)
- Givens J.R., "Familial polycystic ovarian disease", Endocrinol Metab Clin North Am, 17, pp.771~783 (1988)
- Gharani N., "Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism", Hum Mol Genet, 6, pp.397~402 (1997)
- Ehrmann D.A., "Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion", Endocr Rev, 16, pp.322~353 (1995)
- Franks S., "Insulin action in the normal and polycystic ovary", Endocrinol Metab Clin North Am, 28, pp.361~378 (1999)
- Nestler J.E., "Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system", J Clin Endocrinol Metab, 83, pp.2001~2005 (1998)
- Willis D., "Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor", J Clin Endocrinol Metab, 80, pp.3788~3790 (1995)
- Hatch R., "Hirsuitism: implications, etiology, and management", Am J Obstet Gynecol, 140, pp.815~830 (1981)
- Kim S.S., "Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl", Arch Dermatol, 136, pp.430~431 (2000)
- Orfanos C.E., "The SAHA syndrome", Horm Res, 54, pp.251~258 (2000)
- Warren-Ulanch J., "Treatment of PCOS in adolescence", Best Pract Res Clin Endocrinol Metab, 20, pp.311~330 (2006)
- Salmi D.J., "Screening for and treatment of polycystic ovary syndrome in teenagers", Exp Biol Med (Maywood), 229, pp.369~377 (2004)
- Coviello A.D., "Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance", J Clin Endocrinol Metab, 91, pp.492~497 (2006)
- Moll G.W., "Testosterone binding and free plasma androgen concentrations under physiological conditions:characterization by flow dialysis technique", J Clin Endocrinol Metab, 49, pp.730~736 (1979)
- Miller K.K., "Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods", J Clin Endocrinol Metab, 89, pp.525~533 (2004)
- Azziz R., "Clinical review 56: Nonclassic adrenal hyperplasia: current concepts", J Clin Endocrinol Metab, 78, pp.810~815 (1994)
- Lewy V.D., "Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome", J Pediatr, 138, pp.38~44 (2001)
- Rosenfeld R.L., "Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism", J Pediatr Endocrinol Metab, 13, pp.1285~1289 (2000)
- Huber-Buchholz M.M., "Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone", J Clin Endocrinol Metab, 84, pp.1470~1474 (1999)
- Ibanez L., "Rodriquez-Hierro F, de Zegher F. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism", J Clin Endocrinol Metab, 86, pp.3595~3598 (2001)
- Allen H.F., "Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome", J Pediatr Endocrinol Metab, 18, pp.761~768 (2005)
- Elkind-Hirsch K.E., "Thiazolidinediones for the therapeutic management of polycystic ovary syndrome: Impact on Metabolic and Reproductive Abnormalities", Treat Endocrinol, 5, pp.171~187 (2006)
- Sharma S.T., "Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers", Best Pract Res Clin Endocrinol Metab, 20, pp.245~260 (2006)
- Legro R.S., "Carson SA, et al. Clomiphen, metfromin, or both for infertility in the polycystic ovary syndrome", N Engl J Med, 356, pp.551~566 (2007)
- Hassan A., "Polycystic ovary syndrome update in adolescence", Curr Opin Pediatr, 19, pp.389~397 (2007)